FR2419935A1 - Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant - Google Patents

Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant

Info

Publication number
FR2419935A1
FR2419935A1 FR7906563A FR7906563A FR2419935A1 FR 2419935 A1 FR2419935 A1 FR 2419935A1 FR 7906563 A FR7906563 A FR 7906563A FR 7906563 A FR7906563 A FR 7906563A FR 2419935 A1 FR2419935 A1 FR 2419935A1
Authority
FR
France
Prior art keywords
prostaglandin
analogues
pharmaceutical compositions
compositions containing
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7906563A
Other languages
English (en)
Other versions
FR2419935B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of FR2419935A1 publication Critical patent/FR2419935A1/fr
Application granted granted Critical
Publication of FR2419935B1 publication Critical patent/FR2419935B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)

Abstract

L'invention concerne de nouveaux analogues de la prostaglandine I2 . Ces composés ont la formule ci-dessous, dans laquelle R**1 = H, alcoyle, aralcoyle, cycloalcoyle substitué ou non, phényle substitue ou non, alcoxycarbonylalcoyle, hydroxy- ou alcoxyalcoyle, ou dialcoylaminoalcoyle, R**2, R**3, R**4 = H ou alcoyle, B = liaison simple ou groupe alcoylène, n = E à 6, et
FR7906563A 1978-03-18 1979-03-15 Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant Granted FR2419935A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3053178A JPS54125653A (en) 1978-03-18 1978-03-18 Prostaglandin i2 analog, its preparation, and drug composition comprising it as active constituent

Publications (2)

Publication Number Publication Date
FR2419935A1 true FR2419935A1 (fr) 1979-10-12
FR2419935B1 FR2419935B1 (fr) 1981-05-08

Family

ID=12306373

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7906563A Granted FR2419935A1 (fr) 1978-03-18 1979-03-15 Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant

Country Status (7)

Country Link
US (1) US4234597A (fr)
JP (1) JPS54125653A (fr)
CH (1) CH637930A5 (fr)
DE (1) DE2909361A1 (fr)
FR (1) FR2419935A1 (fr)
GB (1) GB2016456B (fr)
IT (1) IT1111997B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55111465A (en) * 1979-02-20 1980-08-28 Ono Pharmaceut Co Ltd Prostaglandin i2 analog and its preparation
US4294759A (en) * 1979-11-15 1981-10-13 The Upjohn Company Structural analogues of 5,6,-dihydro PG1
DE3006865A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Hetero-imino-prostacycline
JPS58164512A (ja) * 1982-03-25 1983-09-29 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
JPS6130554A (ja) * 1984-07-23 1986-02-12 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤
JPS6130519A (ja) * 1984-07-23 1986-02-12 Dainippon Pharmaceut Co Ltd 脳神経細胞の酸素欠乏性疾患治療剤
US5221689A (en) * 1984-07-23 1993-06-22 Ono Pharmaceutical Co., Ltd. Prostaglandin analogues, processes for their preparation and pharmaceutical compositions containing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178367A (en) * 1977-02-21 1979-12-11 Ono Pharmaceutical Co. Ltd. Prostaglandin I2 analogues
US4097489A (en) * 1977-06-17 1978-06-27 The Upjohn Company 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds

Also Published As

Publication number Publication date
JPS6228788B2 (fr) 1987-06-23
JPS54125653A (en) 1979-09-29
DE2909361A1 (de) 1979-09-27
GB2016456B (en) 1982-08-25
FR2419935B1 (fr) 1981-05-08
IT1111997B (it) 1986-01-13
CH637930A5 (fr) 1983-08-31
DE2909361C2 (fr) 1988-03-10
GB2016456A (en) 1979-09-26
US4234597A (en) 1980-11-18
IT7920978A0 (it) 1979-03-14

Similar Documents

Publication Publication Date Title
FR2422635A1 (fr) Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant
FR2416234A1 (fr) Derives de metronidazole et compositions pharmaceutiques en contenant
FR2398748A1 (fr) Nouveaux derives d'imidazoquinazoline, leur preparation et leur application en tant que medicaments
FR2442849A1 (fr)
FR2403333A1 (fr) Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant
FR2418794A1 (fr) Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant
FR2374307A1 (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
FI870589A (fi) Ny farmaceutisk sammansaettning och foerfarande foer framstaellning av den.
FR2404634A1 (fr) Composes de thiazole et compositions pharmaceutiques en contenant
FR2404005A1 (fr) Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant
FR2381043A1 (fr) Nouveaux analogues de prostaglandines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2388793A1 (fr) Azetidinyl-acetonitriles et -acetamides, compositions antiarythmiques contenant ces composes et utilisation de ces compositions
FR2419935A1 (fr) Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant
FR2434572A1 (fr) Derives d'oximes pour la protection des cultures
FR2415636A1 (fr) Nouveaux derives de la guanidine, leur preparation et leur application comme medicaments
FR2442844A1 (fr) Analogues de la prostaglandine i1 et compositions pharmaceutiques les contenant
BE904656A (fr) Ethers cyclopentyliques, leur preparation et formulations pharmaceutiques les contenant.
FR2453152A1 (fr) Nouveaux derives de prostaglandine et medicament les contenant
FR2378777A1 (fr) Nouveaux analogues de prostaglandines
FR2372190A1 (fr) Composes organiques du silicium comprenant au moins un radical alcenyloxy et compositions thermodurcissables les contenant
FR2375211A1 (fr) Nouveaux acides sulfamoylbenzoiques, leur preparation et leur application en tant que medicaments
FR2359120A1 (fr) Nouveaux composes polypeptidiques, leur preparation et leur application comme medicaments
FR2380267A1 (fr) Nouveaux derives de 3-phenyl-oxazolidine-2,4-dione, leur preparation et leur application en tant que microbicides
FR2432506A1 (fr) Nouveaux derives de 6-methoxy-2-acetylnaphtalene oxime, leur preparation et leur application en tant que medicaments
KR850001663A (ko) 살충 및 응애류 박멸제 조성물

Legal Events

Date Code Title Description
ST Notification of lapse